Transcripta Bio

Palo Alto, United States

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

$10.0M raised

Apr 2024

Venture - Series Unknown

Biotechnology Medical

Top Investors

BlueYard CapitalJazz Venture Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Transcripta Bio

How much funding has Transcripta Bio raised?

Transcripta Bio has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.

Who are Transcripta Bio's investors?

Transcripta Bio's investors include BlueYard Capital, Jazz Venture Partners.

Where is Transcripta Bio headquartered?

Transcripta Bio is headquartered in Palo Alto, United States.

What does Transcripta Bio do?

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

What stage is Transcripta Bio at?

Transcripta Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 29, 2024.

MLA

"Transcripta Bio — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/transcripta-bio. Accessed July 1, 2026.

APA

VCBacked. (2024). Transcripta Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/transcripta-bio

Wikipedia (cite web)

{{cite web |title=Transcripta Bio — Funding & Investors |url=https://www.vcbacked.co/company/transcripta-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 29, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K